Cardiovascular Systems Report issue

For profit Phase 3
Founded: St Paul MN United States (1989)
Status: Acquired by Abbott

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Cardiovascular Systems Inc

Active Ingredients

Drugs in Phase 3 Trials (1)

Key: Cardiovascular Systems (0) Acquired (1)

faropenem medoxomil (Fropenem) (2 trials)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 2
  • # of Trial APIs: 1